LLY-507 Sole GMP Manufacturer
LLY-507 stable novel crystalline or amorphous form both we have, LLY-507no any IP problem. LLY-507 DMF filling, free sample of LLY-507.
EOS Med Chem have already carried out LLY-507 batch production, also have completed the development of quality standards and process validation. The stable process is the guarantee of product quality. For LLY-507 , we use HPLC-UV detection instead of other companies' HPLC-ELSD test, Our detection method is more sensitive.
Below is LLY-507 Intermeidates list, most from GMP plant:
LLY-507 HNMR, MASS, COA, MSDS we have.
LLY-507, free sample, welcome to ask:
2019 CHINA CPHI E2A62
2019 WORLD CPHI 101C45
FDA 2015-2018 New API and Intermediates, Clinical Phase II, III Intermediates, GMP Custom synthesis, DMF filling, I am big.
R&D Center: 8000 sq, More than 100 hoods
Pilot Plant: 20000sq, 40 reactors from 5-200L
Manufacturing Site: 800000sq, 40 reactors from 100-5000L
Web: www.eosmedchem.com
Email: info@eosmedchem.com; eosmedchem@gmail.com
LLY-507 stable novel crystalline or amorphous form both we have, LLY-507no any IP problem. LLY-507 DMF filling, free sample of LLY-507.
EOS Med Chem have already carried out LLY-507 batch production, also have completed the development of quality standards and process validation. The stable process is the guarantee of product quality. For LLY-507 , we use HPLC-UV detection instead of other companies' HPLC-ELSD test, Our detection method is more sensitive.
Below is LLY-507 Intermeidates list, most from GMP plant:
| LLY-507, Intermediate 1352413-06-9, stock 3.2kg, assay 98.7%, White powder. |
| LLY-507, Intermediate 1793053-37-8, stock 7.6kg, assay 98.8%, White powder. |
| LLY-507, Intermediate 188813-07-2, stock 4kg, assay 98.4%, White powder. |
| LLY-507, Intermediate 453566-15-9, stock 8.3kg, assay 98.7%, White powder. |
| LLY-507, Intermediate 494773-35-2, stock 8.5kg, assay 98.9%, White powder. |
| LLY-507, Intermediate 690261-03-1, stock 1.6kg, assay 98.6%, White powder. |
LLY-507 HNMR, MASS, COA, MSDS we have.
LLY-507, free sample, welcome to ask:
2019 CHINA CPHI E2A62
2019 WORLD CPHI 101C45
FDA 2015-2018 New API and Intermediates, Clinical Phase II, III Intermediates, GMP Custom synthesis, DMF filling, I am big.
R&D Center: 8000 sq, More than 100 hoods
Pilot Plant: 20000sq, 40 reactors from 5-200L
Manufacturing Site: 800000sq, 40 reactors from 100-5000L
Web: www.eosmedchem.com
Email: info@eosmedchem.com; eosmedchem@gmail.com
